Martin Renke

Title: Martin Renke: Innovator in Photodynamic Therapy

Introduction

Martin Renke is a notable inventor based in Coquitlam, Canada. He has made significant contributions to the field of medical technology, particularly in the area of photodynamic therapy. With a total of 2 patents, Renke's work focuses on innovative treatments for immune dysfunction diseases.

Latest Patents

Renke's latest patents include groundbreaking methods for treating multiple sclerosis and rheumatoid arthritis using photodynamic therapy. The first patent outlines a protocol where a photoactive compound is administered to the affected subject, allowing it to distribute throughout the body. The subject is then irradiated to activate the compound, which can also be applied extracorporeally to the subject's blood. In cases of rheumatoid arthritis, localized treatment at the joints is also a viable option. The second patent details a method for selectively reducing activated leukocyte cell populations, further emphasizing the effectiveness of photodynamic therapy in treating these conditions.

Career Highlights

Throughout his career, Martin Renke has worked with esteemed organizations such as the University of British Columbia and Quadra Logic Technologies, Inc. His experience in these institutions has allowed him to develop and refine his innovative approaches to medical treatment.

Collaborations

Renke has collaborated with notable colleagues, including Simon Leong and Agnes How-Ching Chan. Their combined expertise has contributed to the advancement of research in photodynamic therapy.

Conclusion

Martin Renke's contributions to the field of medical technology through his patents and collaborations highlight his commitment to improving treatment options for patients with immune dysfunction diseases. His innovative approaches continue to pave the way for future advancements in photodynamic therapy.